Serum amyloid P component in chronic renal failure and dialysis
- 30 August 1991
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 200 (2-3) , 191-199
- https://doi.org/10.1016/0009-8981(91)90090-y
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.Journal of Clinical Investigation, 1990
- β2-Microglobulin Amyloidosis in a Patient Treated Exclusively by Continuous Ambulatory Peritoneal DialysisAmerican Journal of Kidney Diseases, 1990
- Beta-2-Microglobulin Amyloidosis in Long-Term Dialysis PatientsAmerican Journal of Nephrology, 1989
- Continuous Ambulatory Peritoneal Dialysis Does Not Prevent the Development of Dialysis-Associated AmyloidosisNephron, 1989
- DIAGNOSTIC RADIONUCLIDE IMAGING OF AMYLOID: BIOLOGICAL TARGETING BY CIRCULATING HUMAN SERUM AMYLOID P COMPONENTThe Lancet, 1988
- Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.The Journal of Experimental Medicine, 1988
- Isolation and Characterization of the Complete Complementary and Genomic DNA Sequences of Human Serum Amyloid P Component1The Journal of Biochemistry, 1986
- Confidence intervals rather than P values: estimation rather than hypothesis testing.BMJ, 1986
- Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A ProteinPublished by Elsevier ,1983
- Isolation of human C-reactive protein and serum amyloid P componentJournal of Immunological Methods, 1982